Genetix Pharmaceuticals Secures $35M in Series B Funding (Business Wire via Yahoo! Finance)

12 March 2010, 5:00 am

CAMBRIDGE, Mass.----Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments for severe genetic disorders, announced today that it has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital.... Read More »

More Topics from "News"

• Celebrating The 100th Birthday Of F. L. Bartels (Ghanaweb.com)
• Genetix Pharmaceuticals Appoints Mitchell Finer, Ph.D. as Chief Scientific Officer (Business Wire via Yahoo! Finance)
• John Davoll (Guardian Unlimited)
• 2010 Academy Award Winners Lauded for Realism in Visual Effects (Marketwire via Yahoo! Finance)
• Fifth U.S. Patent Issued to Jumptap in Nine Months (Marketwire via Yahoo! Finance)
• Expert Consortium Launches Chemistry Playbook®, Expedited CMC Solutions From Cambridge Major Laboratories, Xcelience ... (Business Wire via Yahoo! Finance)
• Cambridge looking for Board of Examiners members (Cambridge Chronicle & Cambridge Tab)
• /CORRECTION - MIT Enterprise Forum of Cambridge Presents "The Sustainability Revolution: What Does It Mean Today to ... (Marketwire via Yahoo! Finance)
• MIT Enterprise Forum of Cambridge Presents "The Sustainability Revolution: What Does It Mean Today to Investors ... (Marketwire via Yahoo! Finance)